People with systemic sclerosis (SSc) have poorer survival when they also have both interstitial lung disease (ILD) and…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
More than half of the people with systemic sclerosis (SSc) in a study were malnourished under recent French guidelines,…
Skin symptoms not due to fibrosis or scarring among people with systemic sclerosis (SSc) sine scleroderma can associate with…
A physiotherapy program improved sexual function and quality of life, while also preventing the deterioration in functional ability in women…
Clinicians in Tunisia highlighted the importance of screening for self-reactive antibodies, or autoantibodies, in localized scleroderma cases after a…
People with systemic sclerosis (SSc) have poorer quality of life and survival when they also have pulmonary arterial hypertension…
The degree of skin tightening is associated with changed levels of proteins implicated in inflammation and cell death among…
Systemic sclerosis (SSc) patients with primary biliary cholangitis (PBC), a disease that causes inflammation and scarring of the liver…
An index comprising three blood biomarkers was strongly associated with a diagnosis of interstitial lung disease (ILD) in systemic…
Oxygenated hemoglobin may be a new prognosis biomarker for systemic sclerosis (SSc) patients screened for pulmonary hypertension (PH),…